Cancer immunotherapy - PDFSEARCH.IO - Document Search Engine

Cancer immunotherapy
Results: 490

#	Item
421	UPDATE ON ADVANCED PROTEOME THERAPEUTICS’ ANTICANCER PROGRAM May 22, 2014 Trading Symbol: TSX-V: APC VANCOUVER, BRITISH COLUMBIA - Advanced Proteome Therapeutics Corporation (“APC” or the Add to Reading List Source URL: www.advancedproteome.com Language: English - Date: 2014-05-23 00:36:23 Ribbon symbolism Cancer research Cancer immunotherapy Adenomatous polyposis coli Breast cancer Targeted therapy Cancer vaccine Lloyd J. Old Medicine Biology Oncology
422	Corporate Presentation May 2014 Medigene: A publicy quoted German biotech with focus on immunotherapies to treat hematological malignancies Add to Reading List Source URL: www.medigene.de Language: English - Date: 2014-05-21 04:14:07 Immune system T cells Immunotherapy Dendritic cell Autoimmunity Minimal residual disease CD4 T helper cell Cancer immunotherapy Immunology Medicine Biology
423	Corporate Presentation May 2014 Medigene: A publicy quoted German biotech with focus on immunotherapies to treat hematological malignancies Add to Reading List Source URL: www.medigene.com Language: English - Date: 2014-05-21 04:14:07 Immune system T cells Immunotherapy Dendritic cell Autoimmunity Minimal residual disease CD4 T helper cell Cancer immunotherapy Immunology Medicine Biology
424	Translational Research Success Stories from AIRI Member Institutes Add to Reading List Source URL: www.airi.org Language: English - Date: 2012-02-02 13:58:02 National Institutes of Health Cancer research Immunotherapy Fred Hutchinson Cancer Research Center Melanoma Sanford-Burnham Medical Research Institute Wistar Institute Management of cancer Medicine Cancer organizations Cancer treatments
425	Cancer Immunotherapy This year marks a turning point in cancer, as long-sought efforts to unleash the immune system against tumors are paying off—even if the future remains a question mark History’s path is unchartab Add to Reading List Source URL: www.virotherapy.eu Language: English - Date: 2014-01-24 05:34:59 Bristol-Myers Squibb Ipilimumab Cancer immunotherapy Melanoma Immunotherapy CTLA-4 PD-1 Steven Rosenberg Management of cancer Medicine Cancer treatments Immunology
426	For personal use only ASX and Media Release Progress in CAVATAK Phase 2 Melanoma Trial Updated data presented at Immunotherapy Session of American Add to Reading List Source URL: www.asx.com.au Language: English - Date: 2014-06-02 20:01:50 Ribbon symbolism Viruses Immunology Immunotherapy Cancer immunotherapy Melanoma Oncolytic virus Management of cancer Breast cancer Medicine Cancer treatments Experimental cancer treatments
427	For personal use only ASX and Media Release CAVATAK Cancer Immunotherapy: Progress in Phase 2 Melanoma Trial Add to Reading List Source URL: www.asx.com.au Language: English - Date: 2014-05-14 20:06:35 Ribbon symbolism Melanoma Immunotherapy Oncolytic virus Prostate cancer Management of cancer American Society of Clinical Oncology Breast cancer Cancer immunotherapy Medicine Cancer treatments Viruses
428	CALM study: A phase II study of an intratumorally delivered oncolytic immunotherapeutic agent, Coxsackievirus A21, in patients with stage IIIc and stage IV malignant melanoma. Robert H.I. Andtbacka, Brendan Curti, Howard Add to Reading List Source URL: www.viralytics.com Language: English - Date: 2014-06-02 19:54:51 Experimental cancer treatments Oncology Breast cancer Immunotherapy Oncolytic virus Response Evaluation Criteria in Solid Tumors ICAM-1 Metastasis Breast cancer treatment Medicine Ribbon symbolism Melanoma
429	Meeting Highlights American Association for Cancer Research and American Psychiatric Association Add to Reading List Source URL: www.pharmscope.com Language: English - Date: 2014-06-07 18:41:22 Neurotechnology Immunology Mood disorders Electroconvulsive therapy Melanoma Transcranial magnetic stimulation Antidepressant Immunotherapy PD-1 Medicine Psychiatry Treatment of bipolar disorder
430	Oncology Key Themes May, 2014 Introduction With the recent conclusion of the annual meeting of the American Association for Cancer Research (AACR) at San Diego (April 4-9) and the upcoming annual conference of the Americ Add to Reading List Source URL: www.smartanalyst.com Language: English - Date: 2014-05-14 05:06:25 Ribbon symbolism Bristol-Myers Squibb Lung cancer Targeted therapy Ipilimumab Erlotinib Immunotherapy Non-small-cell lung carcinoma Cancer immunotherapy Medicine Oncology Melanoma

UPDATE